Therma Bright Inc
XTSX:THRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (19.1), the stock would be worth CA$-0.05 (199% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -19.2 | CA$0.06 |
0%
|
| Industry Average | 19.1 | CA$-0.05 |
-199%
|
| Country Average | 22 | CA$-0.06 |
-215%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Therma Bright Inc
XTSX:THRM
|
3.4m CAD | -19.2 | -0.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 64.9 | 56.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 29.4 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 22.3 | 37.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 27.4 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 29.6 | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 36.2 | 43.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 41.1 | 18.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 45.4 | 42.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 17.5 | 24 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 17.9 | 20.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.2 |
| Median | 22 |
| 70th Percentile | 36 |
| Max | 116 589.8 |
Other Multiples
Therma Bright Inc
Glance View
Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is a developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other diagnostic and medical device technologies that help test for illnesses and assist with pain management. The firm is focused on providing consumers and medical professionals with solutions that addresses medical and healthcare challenges. The company also provides a technology that delivers non-invasive, and pain-free skincare. Its product offerings include AcuVid, which is an antigen and antibody rapid screening test for COVID-19; Venowave, is a Deep Vein Thrombosis (DVT) prevention pump specifically designed for use at home; InterceptCS, is a system that provides controlled topical heat without the risk of burning the skin; Benepod, is a hot and cold contrast therapy device for pain relief without pain relieving medication, and TherOZap, provides pain management relief using thermal therapy for insect bites and stings.
